|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 61.96 USD | -2.12% |
|
-4.35% | +38.03% |
| 18/07 | Many US employers plan to pare health benefits as weight-loss spending soars | RE |
| 18/07 | Elevance cuts forecast as US health insurers battle higher costs | RE |
| Capitalization | 78.38B 67.25B 62.66B 58.3B 108B 6,750B 120B 757B 286B 3,165B 294B 288B 11,634B | P/E ratio 2025 * |
14.3x | P/E ratio 2026 * | 11x |
|---|---|---|---|---|---|
| Enterprise value | 131B 112B 104B 97.08B 179B 11,241B 200B 1,261B 476B 5,270B 490B 479B 19,373B | EV / Sales 2025 * |
0.34x | EV / Sales 2026 * | 0.31x |
| Free-Float |
70.66% | Yield 2025 * |
4.46% | Yield 2026 * | 4.58% |
More valuation ratios
* Estimated data
More news
Last Transcript: CVS Health Corporation
More recommendations
More press releases
More news
| 1 day | -2.12% | ||
| 1 week | -4.35% | ||
| Current month | -10.18% | ||
| 1 month | -7.30% | ||
| 3 months | -7.92% | ||
| 6 months | +17.75% | ||
| Current year | +38.03% |
| 1 week | 61.5 |  | 64.77 |
| 1 month | 61.5 | | 70.23 |
| Current year | 44.11 | | 72.51 |
| 1 year | 43.56 | | 72.51 |
| 3 years | 43.56 | | 107.26 |
| 5 years | 43.56 | | 111.25 |
| 10 years | 43.56 | | 113.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 61 | 17/10/2024 |
Prem Shah
PSD | President | 45 | 06/11/2024 |
Brian Newman
DFI | Director of Finance/CFO | 56 | 12/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 73 | 01/03/2007 |
Anne Finucane
BRD | Director/Board Member | 72 | 20/01/2011 |
| Director/Board Member | 70 | 05/03/2015 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 3.92% | 21 M€ | +4.92% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.12% | -4.35% | +4.01% | -35.99% | 78.38B | ||
| -0.41% | -3.98% | +12.09% | +102.67% | 86.88B | ||
| -0.87% | -2.50% | +35.26% | +50.39% | 26.84B | ||
| +0.16% | -3.57% | -10.56% | +28.54% | 23.66B | ||
| -1.42% | -2.36% | +15.30% | -0.90% | 20.4B | ||
| -0.76% | -0.70% | +14.31% | +22.14% | 18.63B | ||
| -0.05% | -0.39% | +31.36% | +200.17% | 16.26B | ||
| -1.40% | -0.69% | +25.01% | +2.07% | 15.71B | ||
| -2.16% | -0.26% | +30.30% | +233.45% | 13.73B | ||
| -2.05% | -1.23% | +16.06% | +26.50% | 13.08B | ||
| Average | -1.11% | -2.02% | +17.31% | +62.90% | 31.36B | |
| Weighted average by Cap. | -1.10% | -3.02% | +13.30% | +48.98% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 387B 332B 309B 288B 531B 33,333B 593B 3,738B 1,411B 15,628B 1,452B 1,422B 57,446B | 403B 346B 322B 300B 553B 34,680B 617B 3,889B 1,468B 16,260B 1,510B 1,479B 59,769B |
| Net income | 5.62B 4.82B 4.49B 4.18B 7.71B 484B 8.61B 54.26B 20.48B 227B 21.08B 20.64B 834B | 7.3B 6.27B 5.84B 5.43B 10.02B 629B 11.19B 70.53B 26.63B 295B 27.39B 26.83B 1,084B |
| Net Debt | 52.14B 44.74B 41.69B 38.78B 71.56B 4,491B 79.9B 504B 190B 2,106B 196B 192B 7,740B | 46.81B 40.16B 37.42B 34.82B 64.24B 4,032B 71.73B 452B 171B 1,890B 176B 172B 6,948B |
More financial data
* Estimated data
Employees
259,500
Calendar
22/07
- Détachement de
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/07/25 | 61.96 $ | -2.12% | 8,612,043 |
| 17/07/25 | 63.30 $ | -0.78% | 7,352,264 |
| 16/07/25 | 63.80 $ | -0.22% | 5,830,963 |
| 15/07/25 | 63.94 $ | -0.65% | 5,956,059 |
| 14/07/25 | 64.36 $ | -0.65% | 6,864,509 |
Delayed Quote Nyse, 19 July 2025 at 06:00 am AEST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
61.96USD
Average target price
79.61USD
Spread / Average Target
+28.49%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition